HolderBook

Empery Asset Management, LP

Reported holdings as of Q2 2026, from 7 quarterly filings.

CIK
1469336
Reported value
$86.5M
Positions
32
Top 10 weight
90.7%
Filed
2026-08-11
Days after quarter end
42

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
X4 PHARMACEUTICALS INCXFOR$32.4M6,930,59137.43%-7.07pp3q-22.5%-$9.4M
EMPERY DIGITAL INCEMPD$10.4M2,930,34512.06%-2.87pp3qHELD
NERVGEN PHARMA CORPNGEN$8.2M4,000,0009.53%-newNEW
PRECISION BIOSCIENCES INCDTIL$6.1M776,0937.05%-5.99pp3q-60.6%-$9.4M
CLENE INCCLNN$5.6M916,5326.52%-newNEW
ANNOVIS BIO INCANVS$4.5M2,401,4765.17%-newNEW
LANTERN PHARMA INCLTRN$3.5M842,6694.06%-newNEW
AMC ENTMT HLDGS INCAMC$3.3M1,714,0433.77%-newNEW
TENAYA THERAPEUTICS INCTNYA$2.9M3,863,1153.30%-0.27pp3q-9.9%-$313.2K
ONE AND ONE GREEN TECHNOLOGIYDDL$1.5M761,7061.78%-newNEW
CYNGN INCCYN$1.3M927,0591.49%-0.43pp2q-3.2%-$42.7K
VENU HLDG CORPVENU$1.2M512,8181.35%-2.67pp2q-49.1%-$1.1M
GREENLAND ENERGY COGLNDW$850.0K1,000,0000.98%-newNEW
UR-ENERGY INCURG$843.4K620,1360.98%-0.14pp2qHELD
SATELLOS BIOSCIENCE INCMSLE$832.7K107,1000.96%-0.60pp2q-53.5%-$956.3K
JAGUAR URANIUM CORPJAGU$814.1K487,5000.94%-0.67pp2qHELD
CELLECTAR BIOSCIENCES INCCLRB$527.1K189,6050.61%-newNEW
SCYNEXIS INC$514.7K126,4510.60%-newNEW
REIN THERAPEUTICS INCRNTX$385.7K370,8340.45%-newNEW
BTC DIGITAL LTDBTCT$288.9K350,8770.33%-newNEW
BRIACELL THERAPEUTICS CORPBCTXL$267.0K300,0000.31%-0.06pp2qHELD
MARIS TECH LTDMTEKW$58.0K297,6000.07%+0.01pp6qHELD
PARAZERO TECHNOLOGIES LTDPRZO$55.3K113,7710.06%-0.20pp2q-59.7%-$81.9K
DUKE ROBOTICS CORP$45.1K35,0000.05%-newNEW
NUTRIBAND INCNTRBW$40.2K40,2180.05%-0.01pp7qHELD
RENATUS TACTICAL ACQUISRTACW$38.0K50,0000.04%+0.02pp3qHELD
SPECTRAL AI INCMDAIW$18.5K33,3360.02%flat3qHELD
NEXERA TECHNOLOGIES LTDNEXRW$10.4K360,5770.01%flat4qHELD
CEA INDUSTRIES INCBNCWW$9.2K500,0000.01%-0.01pp6qHELD
FGI INDUSTRIES LTDFGIWW$8.0K83,9280.01%+0.01pp6qHELD
NEUROSENSE THERAPEUTICS LTDNRSNW$6.3K100,4020.01%-0.02pp7qHELD
NEXGEL INCNXGLW$3.5K90,0000.00%flat7qHELD

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 75.4%Banks & Lending 12.4%Telecom & Media 5.1%Mining & Metals 1.9%Wholesale & Distribution 1.8%Other sectors 1.8%Not classified 1.6%
 
SectorValueShare
Biotech & Pharma$65.2M75.4%
Banks & Lending$10.7M12.4%
Telecom & Media$4.4M5.1%
Mining & Metals$1.7M1.9%
Wholesale & Distribution$1.5M1.8%
Other sectors$1.5M1.8%
Not classified$1.4M1.6%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q2 2026$86.5M3212071290.7%42
Q1 2026$83.0M3213061292.2%38
Q4 2025$113.4M3123048093.3%42
Q3 2022$16.8M881907663.4%45
Q2 2022$18.5M75110121379.9%43
Q1 2022$21.3M77270292066.7%46
Q4 2021$47.9M70000068.5%42

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.